Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01166230 · ClinicalTrials.gov registry record
Longer-term Recurrence Rates in Patients With Bladder Cancer After Hexvix (Cysview)Fluorescence Cystoscopy/TURB
A clinical trial, sponsored by Photocure.
- Completed
- Registry status
- 551
- Enrollment target
NCT01166230: Completed study, sponsored by Photocure.
NCT01166230 is a clinical trial that has completed, run by Photocure. The registered enrollment target is 551 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01166230 has completed, sponsored by Photocure.
- COMPLETED
- Registry status
- 551 participants
- Enrollment target
Study Summary
The study is intended to investigate whether the improved initial detection and resection of bladder cancer lesions in patients with non-muscle invasive bladder cancer with Hexvix (Cysview) fluorescence cystoscopy/TURB will lead to a longer-term reduction in recurrences compared to standard white light cystoscopy/TURB.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 551 participants |
| Start Date | 2010-06 |
| Est. Completion | 2010-12 |
What the finished NCT01166230 record still lists
NCT01166230 is an observational study that tracks outcomes without assigning an intervention. The registered 551 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01166230 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01166230 about?
NCT01166230 is a clinical study titled "Longer-term Recurrence Rates in Patients With Bladder Cancer After Hexvix (Cysview)Fluorescence Cystoscopy/TURB". The study is intended to investigate whether the improved initial detection and resection of bladder cancer lesions in patients with non-muscle invasive bladder cancer with Hexvix (Cysview) fluorescence cystoscopy/TURB will lead to a longer-term reduction in recurrences compared to standard white li...
What is the current status of trial NCT01166230?
This trial is currently completed. The enrollment target is 551 participants. The study started on 2010-06. Estimated completion is 2010-12.
Who is sponsoring clinical trial NCT01166230?
This trial is sponsored by Photocure, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06217809 · 552 participants · NA
EmpowHer is Prevention Curriculum for Youth Ages 10-15 Years.
- NCT07146022 · 552 participants · Phase 3
Safety and Efficacy of VDPHL01 in Females With Androgenetic Alopecia (AGA)
- NCT01852448 · 550 participants
Genetics of Insulin and Incretins in Cystic Fibrosis
- NCT02995252 · 550 participants
The HOPE Study: Characterizing Patients With Hepatitis B and C
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia